Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuehan Ren

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Iscience|June 23, 2025
Entropy measures for quantifying complexity in digital pathology and spatial omicsXiao Li, Xuehan Ren, Raghavan Venugopal
Biostatistics & Epidemiology|December 20, 2021
Dynamic prediction using joint models of longitudinal and recurrent event data: A Bayesian perspectiveXuehan Ren, Jue Wang, Sheng Luo
Journal of Health Psychology|September 20, 2021
Parents' parenting styles differences are associated with lifetime suicidal ideation: Evidence from Chinese medical college studentsZhen Gui, Xuehan Ren, Xiao Li, et al.
Journal of Neurology|July 17, 2017
Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohortAnne-Marie Wills, Ruosha Li, Adriana Pérez, et al.
Movement Disorders Clinical Practice|December 6, 2018
Missing Data in the Unified Dysksinesia Rating Scale (UDysRS)Sheng Luo, Xuehan Ren, Weilu Han, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2021
Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of ChangeXuehan Ren, Jeffrey Lin, Glenn T Stebbins, et al.
Parkinsonism & Related Disorders|September 10, 2019
Successful use of the Unified Dyskinesia Rating Scale regardless of PD- or dyskinesia-durationXuehan Ren, Jeffrey Lin, Sheng Luo, et al.
Journal of Crohn'S & Colitis|February 17, 2024
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled TrialWalter Reinisch, Jean-Frederic Colombel, Geert R D'Haens, et al.
Neuroepidemiology|June 17, 2020
Validation of the Hebrew Version of the Unified Dyskinesia Rating ScaleAchinoam Faust-Socher, Saar Anis, Meir Kestenbaum, et al.
Journal of Movement Disorders|March 15, 2022
Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating ScalePriya Jagota, Prachaya Srivanitchapoom, Sitthi Petchrutchatachart, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Iscience|June 23, 2025
Entropy measures for quantifying complexity in digital pathology and spatial omicsXiao Li, Xuehan Ren, Raghavan Venugopal
Biostatistics & Epidemiology|December 20, 2021
Dynamic prediction using joint models of longitudinal and recurrent event data: A Bayesian perspectiveXuehan Ren, Jue Wang, Sheng Luo
Journal of Health Psychology|September 20, 2021
Parents' parenting styles differences are associated with lifetime suicidal ideation: Evidence from Chinese medical college studentsZhen Gui, Xuehan Ren, Xiao Li, et al.
Journal of Neurology|July 17, 2017
Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohortAnne-Marie Wills, Ruosha Li, Adriana Pérez, et al.
Movement Disorders Clinical Practice|December 6, 2018
Missing Data in the Unified Dysksinesia Rating Scale (UDysRS)Sheng Luo, Xuehan Ren, Weilu Han, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2021
Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of ChangeXuehan Ren, Jeffrey Lin, Glenn T Stebbins, et al.
Parkinsonism & Related Disorders|September 10, 2019
Successful use of the Unified Dyskinesia Rating Scale regardless of PD- or dyskinesia-durationXuehan Ren, Jeffrey Lin, Sheng Luo, et al.
Journal of Crohn'S & Colitis|February 17, 2024
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled TrialWalter Reinisch, Jean-Frederic Colombel, Geert R D'Haens, et al.
Neuroepidemiology|June 17, 2020
Validation of the Hebrew Version of the Unified Dyskinesia Rating ScaleAchinoam Faust-Socher, Saar Anis, Meir Kestenbaum, et al.
Journal of Movement Disorders|March 15, 2022
Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating ScalePriya Jagota, Prachaya Srivanitchapoom, Sitthi Petchrutchatachart, et al.
Pageof 2